Corrigendum to “Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3369 patients in the ARCAD database” (European Journal of Cancer (2023) 178 (162–170), (S0959804922013259), (10.1016/j.ejca.2022.10.022))

Ofer Margalit; William S. Harmsen; Einat Shacham-Shmueli; Molly M. Voss; Ben Boursi; Anna D. Wagner; Romain Cohen; Curtis L. Olswold; Leonard B. Saltz; Daniel A. Goldstein; Herbert Hurwitz; Niall C. Tebbutt; Fairooz F. Kabbinavar; Richard A. Adams; Benoist Chibaudel; Axel Grothey; Takayuki Yoshino; John Zalcberg; Aimery de Gramont; Qian Shi; Heinz Josef Lenz

doi:10.1016/j.ejca.2023.113339

Corrigendum to “Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3369 patients in the ARCAD database” (European Journal of Cancer (2023) 178 (162–170), (S0959804922013259), (10.1016/j.ejca.2022.10.022))

Ofer Margalit^*, William S. Harmsen, Einat Shacham-Shmueli, Molly M. Voss, Ben Boursi, Anna D. Wagner, Romain Cohen, Curtis L. Olswold, Leonard B. Saltz, Daniel A. Goldstein, Herbert Hurwitz, Niall C. Tebbutt, Fairooz F. Kabbinavar, Richard A. Adams, Benoist Chibaudel, Axel Grothey, Takayuki Yoshino, John Zalcberg, Aimery de Gramont, Qian ShiHeinz Josef Lenz

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate

Abstract

The authors regret that Fig. 2B was accidently excluded from the final manuscript. This has now been corrected. The authors would like to apologise for any inconvenience caused[Formula presented].

Original language	English
Article number	113339
Journal	European Journal of Cancer
Volume	194
DOIs	https://doi.org/10.1016/j.ejca.2023.113339
State	Published - Nov 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ejca.2023.113339

Fingerprint

Dive into the research topics of 'Corrigendum to “Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3369 patients in the ARCAD database” (European Journal of Cancer (2023) 178 (162–170), (S0959804922013259), (10.1016/j.ejca.2022.10.022))'. Together they form a unique fingerprint.

Cite this

Margalit, O., Harmsen, W. S., Shacham-Shmueli, E., Voss, M. M., Boursi, B., Wagner, A. D., Cohen, R., Olswold, C. L., Saltz, L. B., Goldstein, D. A., Hurwitz, H., Tebbutt, N. C., Kabbinavar, F. F., Adams, R. A., Chibaudel, B., Grothey, A., Yoshino, T., Zalcberg, J., de Gramont, A., ... Lenz, H. J. (2023). Corrigendum to “Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3369 patients in the ARCAD database” (European Journal of Cancer (2023) 178 (162–170), (S0959804922013259), (10.1016/j.ejca.2022.10.022)). European Journal of Cancer, 194, Article 113339. https://doi.org/10.1016/j.ejca.2023.113339

Margalit, Ofer ; Harmsen, William S. ; Shacham-Shmueli, Einat et al. / Corrigendum to “Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma : Pooled analysis of 3369 patients in the ARCAD database” (European Journal of Cancer (2023) 178 (162–170), (S0959804922013259), (10.1016/j.ejca.2022.10.022)). In: European Journal of Cancer. 2023 ; Vol. 194.

@article{dc816b707b1c4a599901b4489ca252e8,

title = "Corrigendum to “Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3369 patients in the ARCAD database” (European Journal of Cancer (2023) 178 (162–170), (S0959804922013259), (10.1016/j.ejca.2022.10.022))",

abstract = "The authors regret that Fig. 2B was accidently excluded from the final manuscript. This has now been corrected. The authors would like to apologise for any inconvenience caused[Formula presented].",

author = "Ofer Margalit and Harmsen, {William S.} and Einat Shacham-Shmueli and Voss, {Molly M.} and Ben Boursi and Wagner, {Anna D.} and Romain Cohen and Olswold, {Curtis L.} and Saltz, {Leonard B.} and Goldstein, {Daniel A.} and Herbert Hurwitz and Tebbutt, {Niall C.} and Kabbinavar, {Fairooz F.} and Adams, {Richard A.} and Benoist Chibaudel and Axel Grothey and Takayuki Yoshino and John Zalcberg and {de Gramont}, Aimery and Qian Shi and Lenz, {Heinz Josef}",

note = "Publisher Copyright: {\textcopyright} 2023 The Authors",

year = "2023",

month = nov,

doi = "10.1016/j.ejca.2023.113339",

language = "אנגלית",

volume = "194",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd.",

}

Margalit, O, Harmsen, WS, Shacham-Shmueli, E, Voss, MM, Boursi, B, Wagner, AD, Cohen, R, Olswold, CL, Saltz, LB, Goldstein, DA, Hurwitz, H, Tebbutt, NC, Kabbinavar, FF, Adams, RA, Chibaudel, B, Grothey, A, Yoshino, T, Zalcberg, J, de Gramont, A, Shi, Q & Lenz, HJ 2023, 'Corrigendum to “Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3369 patients in the ARCAD database” (European Journal of Cancer (2023) 178 (162–170), (S0959804922013259), (10.1016/j.ejca.2022.10.022))', European Journal of Cancer, vol. 194, 113339. https://doi.org/10.1016/j.ejca.2023.113339

Corrigendum to “Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3369 patients in the ARCAD database” (European Journal of Cancer (2023) 178 (162–170), (S0959804922013259), (10.1016/j.ejca.2022.10.022)). / Margalit, Ofer; Harmsen, William S.; Shacham-Shmueli, Einat et al.
In: European Journal of Cancer, Vol. 194, 113339, 11.2023.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Corrigendum to “Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma

T2 - Pooled analysis of 3369 patients in the ARCAD database” (European Journal of Cancer (2023) 178 (162–170), (S0959804922013259), (10.1016/j.ejca.2022.10.022))

AU - Margalit, Ofer

AU - Harmsen, William S.

AU - Shacham-Shmueli, Einat

AU - Voss, Molly M.

AU - Boursi, Ben

AU - Wagner, Anna D.

AU - Cohen, Romain

AU - Olswold, Curtis L.

AU - Saltz, Leonard B.

AU - Goldstein, Daniel A.

AU - Hurwitz, Herbert

AU - Tebbutt, Niall C.

AU - Kabbinavar, Fairooz F.

AU - Adams, Richard A.

AU - Chibaudel, Benoist

AU - Grothey, Axel

AU - Yoshino, Takayuki

AU - Zalcberg, John

AU - de Gramont, Aimery

AU - Shi, Qian

AU - Lenz, Heinz Josef

PY - 2023/11

Y1 - 2023/11

N2 - The authors regret that Fig. 2B was accidently excluded from the final manuscript. This has now been corrected. The authors would like to apologise for any inconvenience caused[Formula presented].

AB - The authors regret that Fig. 2B was accidently excluded from the final manuscript. This has now been corrected. The authors would like to apologise for any inconvenience caused[Formula presented].

UR - http://www.scopus.com/inward/record.url?scp=85173446162&partnerID=8YFLogxK

U2 - 10.1016/j.ejca.2023.113339

DO - 10.1016/j.ejca.2023.113339

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

C2 - 37813779

AN - SCOPUS:85173446162

SN - 0959-8049

VL - 194

JO - European Journal of Cancer

JF - European Journal of Cancer

M1 - 113339

ER -

Margalit O, Harmsen WS, Shacham-Shmueli E, Voss MM, Boursi B, Wagner AD et al. Corrigendum to “Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3369 patients in the ARCAD database” (European Journal of Cancer (2023) 178 (162–170), (S0959804922013259), (10.1016/j.ejca.2022.10.022)). European Journal of Cancer. 2023 Nov;194:113339. doi: 10.1016/j.ejca.2023.113339

Corrigendum to “Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3369 patients in the ARCAD database” (European Journal of Cancer (2023) 178 (162–170), (S0959804922013259), (10.1016/j.ejca.2022.10.022))

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this